QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 quoin-pharmaceuticals-files-for-offering-of-up-to-1005m-adss

-SEC Filing

 quoin-pharmaceuticals-q3-eps-671-misses-650-estimate

Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(6.71) per share which missed the analyst consensus estimate ...

 quoin-pharmaceuticals-announces-recruitment-of-three-additional-pediatric-patients-for-its-investigator-led-netherton-syndrome-study-and-reports-9-month-results-from-the-first-patient-treated-with-qrx003-showing-completely-healed-skin-after-9-months-of-whole-body-treatment

Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a late clinical stage, specialty pharmaceu...

 quoin-pharmaceuticals-qnrx-stock-is-skyrocketing-friday-whats-going-on

Quoin Pharmaceuticals shares are trading higher Friday morning after the company announced a private placement financing of up ...

 quoin-pharma-announces-1045m-private-placement-including-165m-upfront-and-88m-in-warrant-linked-upside-priced-above-prior-close

Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceut...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION